Catheter Precision Publishes Results Of Non-Invasive Stereotactic Radioablation Using VIVO In HeartRhythm Case Reports
Portfolio Pulse from Benzinga Newsdesk
Catheter Precision has published results on the use of VIVO for non-invasive stereotactic radioablation in HeartRhythm Case Reports. This development could impact the medical device market, particularly in cardiac treatment technologies.
October 21, 2024 | 12:42 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Catheter Precision's publication of results on VIVO for non-invasive stereotactic radioablation could enhance VTAK's position in the cardiac treatment market.
The publication of results in a reputable journal like HeartRhythm Case Reports suggests a positive reception in the medical community, potentially increasing demand for VIVO and benefiting VTAK's market position.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80